Low Back Pain and Motor Control in Soccer Players

August 14, 2023 updated by: Aynur Demirel, Hacettepe University

Futbolcularda Bel Ağrısının ve Motor Kontrol Etkileniminin Sportif Performansa Etkilerinin İncelenmesi

Identification of the effects of low back pain and motor control influence on soccer players performance.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Enrolling by invitation

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

At least 60 volunteer athletes who playing soccer at least 3 years, not away from field more than 2 weeks, 16 years and older are planned to include this study. All participating athletes in this study will be signed an informed consent form then their demographic information will be recorded. To evaluate disability due to low back pain, musculoskeletal problems and the willingness to participate in sports will be used the Oswestry Disability index, the Nordic Musculoskeletal System questionnaire and the Sport Motivation Scale-2, respectively. The motor control levels of the athletes will be assessed with the motor control test battery (MKTB), the core stability with the Sahrmann's core stability test, core muscles endurance with the sport-specific endurance plank test and side bridge endurance test, the static balance with the stand stork test, the dynamic balance with the lower quadrant y balance test, postural changes with the Corbin Posture Rating Scale, the agility with the T test, speed and coordination with 4-10 shuttle run test, explosive force with long jump test, the kinetic chain with the functional movement screen.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Turkey
      • Ankara, Turkey, 06100
        • Aynur Demirel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

All volunteer employees who are over the age of 16, have been playing football for at least three years, have not been away from football for more than two weeks, play football and meet the inclusion criteria of the study will be included.

Description

Inclusion Criteria:

  • Be over 16 years old,
  • Participating in the soccer training for at least three years,
  • Soccer players who have not stayed away from their sport for more than two weeks

Exclusion Criteria:

  • Any history of orthopedic or neurological injury or pain that may interfere with normal football training or competition during assessment
  • History of spine/lower and upper extremity surgery,
  • Structural deformities such as scoliosis and kyphosis,
  • Having trap neuropathy
  • Soccer players who had injuries other than chronic low back pain in the last 6 months will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Motor control disorder
Time Frame: baseline
Motor control test battery: the test consists of ten different tests (forward bend, return from forward bend, sitting forward lean,sitting knee extension, pelvic tilt, one leg stance,side bending, rocking forward, prone knee flexion, hip abduction).Whether the total score increases, the motor control disorders increase.
baseline
Core stability
Time Frame: baseline
Sharmann's core stability test
baseline
Core muscles endurance
Time Frame: baseline
Sport-specific endurance plank test, right and left side bridge endurance test
baseline
Static balance
Time Frame: baseline
Stand Stork test
baseline
Dynamic balance
Time Frame: baseline
Lower quadrant y balance test
baseline
Agility
Time Frame: baseline
T test
baseline
Speed and coordination
Time Frame: baseline
4-10 Shuttle run test
baseline
Explosive power
Time Frame: baseline
Standing long jump test
baseline
Kinetic chain
Time Frame: baseline
Functional movement screen
baseline

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Nordic Musculoskeletal System Questionnaire
Time Frame: baseline
Evaluates the musculoskeletal system problem. If the athlete indicate a musculoskeletal problem different than low back pain, it will use for screening.
baseline
Sport Motivation Scale-2
Time Frame: baseline
Evaluates willingness to participate in sports. The scale has 6 subparameters indicating sport motivation levels is high or low.
baseline
Oswestry Disability Index
Time Frame: baseline
Evaluate disability due to low back pain. the index measures perceived low back pain related dysfunction. Whether the total score increaeses, the dyscfunction increases.
baseline
Postural changes
Time Frame: baseline
Corbin Posture Rating Scale. Whether the total score increaeses, thepostural problems increases.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
July 7, 2023

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 31, 2023

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 31, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 5, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 5, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 6, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 15, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 14, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • GO 22/110

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low-back Pain

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings